In Response to the Comment by Hechler .: Amotosalen/UVA Pathogen Inactivation Technology Reduces Platelet Activatability, Induces Apoptosis and Accelerates Clearance

Overview

Journal Haematologica

Specialty Hematology

Date 2017 Dec 2

PMID 29192132

Citations 1

Authors

Simona Stivala

Sara Gobbato

Laura Infanti

Martin F Reiner

Nicole Bonetti

Sara C Meyer

Giovanni G Camici

Thomas F Luscher

Andreas Buser

Juerg H Beer

Affiliations

Soon will be listed here.

Citing Articles

Increase of Phosphoprotein Expressions in Amotosalen/UVA-Treated Platelet Concentrates.

Muret C, Crettaz D, Alberio L, Prudent M Transfus Med Hemother. 2024; 51(2):101-110.

PMID: 38584699 PMC: 10996061. DOI: 10.1159/000535060.

References

Newman P, Aster R, Boylan B . Human platelets circulating in mice: applications for interrogating platelet function and survival, the efficacy of antiplatelet therapeutics, and the molecular basis of platelet immunological disorders. J Thromb Haemost. 2007; 5 Suppl 1:305-9. DOI: 10.1111/j.1538-7836.2007.02466.x. View

Boylan B, Berndt M, Kahn M, Newman P . Activation-independent, antibody-mediated removal of GPVI from circulating human platelets: development of a novel NOD/SCID mouse model to evaluate the in vivo effectiveness of anti-human platelet agents. Blood. 2006; 108(3):908-14. PMC: 1895852. DOI: 10.1182/blood-2005-07-2937. View

McCullough J, Vesole D, Benjamin R, Slichter S, Pineda A, Snyder E . Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood. 2004; 104(5):1534-41. DOI: 10.1182/blood-2003-12-4443. View

Janetzko K, Cazenave J, Kluter H, Kientz D, Michel M, Beris P . Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set. Transfusion. 2005; 45(9):1443-52. DOI: 10.1111/j.1537-2995.2005.00550.x. View

Gulliksson H . Additive solutions for the storage of platelets for transfusion. Transfus Med. 2000; 10(4):257-64. DOI: 10.1046/j.1365-3148.2000.00262.x. View

Johnson L, Loh Y, Kwok M, Marks D . In vitro assessment of buffy-coat derived platelet components suspended in SSP+ treated with the INTERCEPT Blood system. Transfus Med. 2013; 23(2):121-9. DOI: 10.1111/tme.12020. View

Kerkhoffs J, van Putten W, Novotny V, Te Boekhorst P, Schipperus M, Zwaginga J . Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction. Br J Haematol. 2010; 150(2):209-17. DOI: 10.1111/j.1365-2141.2010.08227.x. View

Liang S, Pinkevych M, Khachigian L, Parish C, Davenport M, Chong B . Drug-induced thrombocytopenia: development of a novel NOD/SCID mouse model to evaluate clearance of circulating platelets by drug-dependent antibodies and the efficacy of IVIG. Blood. 2010; 116(11):1958-60. DOI: 10.1182/blood-2010-02-268326. View

Bock M, Rahrig S, Kunz D, Lutze G, Heim M . Platelet concentrates derived from buffy coat and apheresis: biochemical and functional differences. Transfus Med. 2002; 12(5):317-24. DOI: 10.1046/j.1365-3148.2002.00392.x. View

10.

Moog S, Mangin P, Lenain N, Strassel C, Ravanat C, Schuhler S . Platelet glycoprotein V binds to collagen and participates in platelet adhesion and aggregation. Blood. 2001; 98(4):1038-46. DOI: 10.1182/blood.v98.4.1038. View

11.

Hechler B, Ohlmann P, Chafey P, Ravanat C, Eckly A, Maurer E . Preserved functional and biochemical characteristics of platelet components prepared with amotosalen and ultraviolet A for pathogen inactivation. Transfusion. 2012; 53(6):1187-200. DOI: 10.1111/j.1537-2995.2012.03923.x. View

12.

Kiminkinen L, Krusius T, Javela K . Evaluation of soluble glycoprotein V as an in vitro quality marker for platelet concentrates: a correlation study between in vitro platelet quality markers and the effect of storage medium. Vox Sang. 2016; 111(2):120-6. DOI: 10.1111/vox.12402. View

13.

Van Aelst B, Feys H, Devloo R, Vanhoorelbeke K, Vandekerckhove P, Compernolle V . Riboflavin and amotosalen photochemical treatments of platelet concentrates reduce thrombus formation kinetics in vitro. Vox Sang. 2015; 108(4):328-39. DOI: 10.1111/vox.12231. View